STAT3 and pulmonary fibrosis: Abnormal activation or suppression of STAT3 is closely linked to the pathogenesis and progression of several pulmonary disorders, such as pulmonary fibrosis, pulmonary infections, and chronic obstructive pulmonary disease (10–12).